Aurobindo Pharma gets USFDA nod for anaesthesia drug

Quoting IQVIA data, Aurobindo Pharma said the approved product has an estimated market size of USD 11 million for the 12 months ending September 2018.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2AcHopE
via IFTTT

0 comments:

Post a Comment